Decomposing Medicare total, Part D, and Part B drug payments among people with Alzheimer's disease and related diseases
These findings underscore the need for targeted interventions in mental health, cardiovascular care, and pharmaceutical policy. Further research is needed to better understand unmeasured drivers of Medicare spending, especially physician-administered drug costs under Part B, among beneficiaries with ADRD.
Authors
- Jie Chen (ORCID: https://orcid.org/0000-0002-4029-4192)
- Seyeon Jang (ORCID: https://orcid.org/0009-0000-0826-6530)
Institutions
- Department of Health Services (US)
- University of Maryland, College Park (US)
Publication Details
- Journal
- Health Affairs Scholar
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1093/haschl/qxaf179
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.13